Citizens Financial Group Inc Invitae Corp Transaction History

Citizens Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$11.71 - $30.29 $14,696 - $38,013	-1,255 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$7.64 - $27.5 $3,384 - $12,182	-443 Reduced 26.09%	1,255 $17,000
Q4 2019 Feb 07, 2020	BUY	$15.02 - $20.57 $25,503 - $34,927	1,698 New	1,698 $27,000
Q3 2019 Nov 01, 2019	SELL	$18.85 - $27.5 $18,850 - $27,500	-1,000 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$10.65 - $25.75 $10,650 - $25,750	1,000 New	1,000 $23,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.